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Fastingdown-regulates thehypothalamus-pituitary-thyroid (HPT)axis activity througha reduction
of thyrotropin releasing hormone (TRH) synthesis in neurons of the parvocellular paraventricular
nucleus of the hypothalamus (PVN). These TRH neurons project to the median eminence (ME),
where TRH terminals are close to the cytoplasmic extensions of b2 tanycytes. Tanycytes express
pyroglutamyl peptidase II (PPII), the TRH-degrading ectoenzyme that controls the amount of TRH
that reaches the anterior pituitary. We tested the hypothesis that regulation of ME PPII activity is
another mechanism by which fasting affects the activity of the HPT axis. Semi-quantitative in situ
hybridization histochemistry data indicated that PPII and deiodinase 2 mRNA levels increased in
tanycytes after 48 h of fasting. This increase was transitory, followed by an increase of PPII activity
in the ME, and a partial reversion of the reduction in PVN pro-TRH mRNA levels and the number
of TRH neurons detected by immunohistochemistry. In fed animals, adrenalectomy and cortico-
sterone treatment did not change ME PPII activity 72 h hour later. Methimazole-induced hypo-
thyroidism produced a profound drop in tanycytes PPII mRNA levels, which was reverted by 3 days
of treatment with T4. The activity of thyroliberinase, the serum isoform of PPII, was increased at
most fasting time points studied. We conclude that delayed increases in both the ME PPII as well
as the thyroliberinase activities in fasted male rats may facilitate the maintenance of the deep
down-regulation of theHPT axis function, in spite of a partial reactivation of TRH expression in the
PVN.
The brain of vertebrates detects adverse environmentalchanges, as food deficit. Homeostatic responses to
food restriction or fasting lead to adjustments in the ac-
tivity of the neuroendocrine axes, which control growth
and energy metabolism. During energy deficits, the hypo-
thalamic-pituitary-thyroid (HPT) axis is regulated
through multiple tissue-specific changes (1). In the para-
ventricular nucleus of the hypothalamus (PVN), food re-
striction or fasting decrease the expression of prothyro-
tropin releasing hormone (pro-TRH) and of PC1/3 and
PC2, convertases that contribute to pro-TRH processing
into mature peptide (2–7). The concentration of TRH in
both the median eminence (ME) and the hypothalamic
portal blood, as well as the level of b-TSH mRNA in an-
terior pituitary, and the concentration of TSH in serum
decrease during fasting (2, 5, 8, 9, 10). A negative energy
balance is associated with decreased liver deiodinase 1
(D1)mRNA levels and activity (11, 12, 13), and increased
catabolism of T4 (14). These events lead to a dramatic
reduction of serum triiodothyronine (T3) and T4 concen-
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trations, which contribute to reducing energy expenditure
when food reserves are low (8, 9).
Down regulation of bothTRHbiosynthesis and release
during fasting likely contributes to the decrease of TRH
concentration in the hypothalamic portal blood, but TRH
hydrolysis in the extracellular space likely adds another
level of control. TRH is hydrolyzed in vitro by pyroglu-
tamyl peptidase II (PPII; EC 3.4.19.6; TRH-degrading ec-
toenzyme), a narrow specificity ectoenzyme (15). PPII is
found in various brain regions, including the mediobasal
hypothalamus (MBH) (16, 17). In the MBH, PPII is ex-
pressed in all tanycyte subtypes (17), a specialized ependy-
mal cell type that forms the central and ventral parts of the
wall of the third ventricle. While a1 and a2 tanycyte sub-
types send basal processes into the dorsomedial and ven-
tromedial nuclei, the b1 and b2 tanycyte subtypes are lo-
calized ventrally, and the b2 tanycytes project basal
processes to the external layer of the ME (18). Functional
evidence suggests PPII regulates TRHconcentration in the
ME extracellular space, before TRH reaches the anterior
pituitary, and thus thyrotropin levels in serum (17). The
expression and activity of PPII in theME are up-regulated
by thyroid hormones; these changes are faster than those
operating on TRH synthesis in the PVN, and may con-
tribute to the negative feedback that adjusts HPT axis
activity (17, 19).
PPII is also expressed in the anterior pituitary, where its
activity is regulated bymultiple hypothalamic and periph-
eral factors, including thyroid hormones that up-regulate
it (15, 20). In this tissue, PPII is not localized to thyro-
trophs, and functional studies in cell culture indicate that
it controlsTRHeffect onprolactin secretion, but notTRH
effect on TSH secretion (21, 22). Additionally, a soluble
PPII isoform, called thyroliberinase, is produced by the
liver (23), and may hydrolyze circulating TRH. Thyroli-
berinase activity is up-regulated by thyroid hormones (24,
25), but the impact of negative energy balance conditions
on the activity of this enzyme is unknown.
The current study aimed to test the hypothesis that PPII
expression and activity in the ME of adult male rats is
adjusted during fasting, as an additional mechanism to
regulate HPT axis activity. The sensitivity of ME PPII ex-
pression and activity to thyroid and adrenal status was
analyzed in fed animals. Additionally, we compared the
dynamics of ME PPII expression and activity with pro-
TRH synthesis in the PVNof fasted animals, and explored
the effect of fasting on the activity of PPII in the anterior
pituitary, serum and the parietal cortex.
Materials and Methods
Animals
Adult male Wistar rats were obtained from the animal care
facility of Instituto de Biotecnología, UNAM, México, except
that for experiment 5 Wistar rats were purchased from Harlan
Laboratories (Mexico), and for experiment 7 we used Sprague-
Dawley rats generated at the animal care facility of the Multi-
disciplinary Institute of Cell Biology (IMBICE). Before experi-
ments, animals were acclimatized for at least 5–10 days to a
12-hour light/12-hour dark cycle (lights between 07:00 and
19:00 hours) in a room with controlled temperature (226 1°C)
and humidity. Rat chow (Harlan 2018SX) and tap water were
provided ad libitum.
Experimental protocols
Experiment 1. Rats (400–450 g, age 120–130 days, n5 5 in
each group) were isolated in individual cages for either 48 or 72
hours and allowed free access to food and water (control ani-
mals), or isolated and deprived of food for either 48 or 72 hours
with water ad libitum (experimental animals). Between 9–11
AM, animals were overdosed with pentobarbital (50 mg/kg ip),
blood withdrawn from aorta, and perfused transcardially with
20 ml 0.01 M PBS (pH 7.4) containing 15 000 U/liter heparin
sulfate, followed by 150 ml 4% paraformaldehyde in PBS. The
brains were rapidly removed and postfixed by immersion in the
same fixative for 2 hours at room temperature. Brain tissue was
cryo-protected in 25% sucrose in PBS at 4°C overnight, snap
frozen on dry ice, and stored at –70°C. Since data were identical
in control animals isolated for either 48 or 72 hours, data from
both groups were pooled.
Experiment 2. Rats, raised 2 per cage since weaning, were
isolated 5 days before initiation of fasting. Animals (300–350 g,
age 78 days, n 5 4 in each group) were separated in 2 experi-
mental groups, either maintained with free access to food and
water, or deprived of food for 48 hours with water ad libitum.
Between 9–12AM, animals were overdosedwith pentobarbital,
blood withdrawn, and brain tissue prepared as described for
experiment 1.
Experiments 3 and 4. Rat weight: 250–300 g, ages 65 or 75
days for experiments 3 or 4 respectively; n 5 5 in each group.
Control animals were isolated for either 36, 48, 60 or 72 hours
and allowed free access to food andwater,whereas experimental
animals were isolated and deprived of food for either 36, 48, 60
or 72h with water ad libitum. Finally, animals were euthanized
by decapitation between 9–12AM, brain, anterior pituitary and
liver removed, and tissues frozen on dry ice; trunk blood was
collected for hormone and metabolite dosage. A brain coronal
slice (bregma –2.12 to –3.6mm) (26) was used to dissect theME
with a sample corer (0.5 mm internal diameter; Fine Science
Tools, Foster City, CA) centered between the base of the brain as
the ventral limit and the floor of third ventricle as a dorsal limit.
The same slice and sample corer were used to obtain parietal
cortex (area 1) samples from the right and left hemispheres.
Experiment 5. Between 9–12 AM rats (270–330 g, age 70
days, n 5 6 in sham and 40% corticosterone / 60% cholesterol
group, and n5 5 for the adrenalectomized and 25% corticoste-
rone / 75% cholesterol groups) were either sham operated, or
bilaterally adrenalectomized under ketamine 100mg/Kg and xy-
lazine 10 mg/Kg anesthesia and implanted with a subcutaneous
corticosterone pellet (27, 28). The pellets were made of either
cholesterol, or 25% corticosterone/75% cholesterol, or 40%
corticosterone/ 60% cholesterol (percentages of w/w). Animals
were maintained 2 per cage with free access to food, and either
water (sham) or 0.5% saline solution (adrenalectomized rats).
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Animals were sacrificed 3 days later, and tissue and blood col-
lected as described for experiments 3 and 4.
Experiment 6. Rats (200–300 g, age 60–75 days) were sep-
arated in five groups: control (intact, n53, vehicle (200ml sterile
saline/ 0.01 N NaOH per 3 days beginning on day 19, n 5 1,
hypothyroid (0.1% methimazole 1 1% sodium perchlorate in
their drinking water per 21 days, n5 2), hypothyroid1 vehicle
(200 ml per 3 days beginning on day 19, n5 3) and hypothyroid
1 L-T4 (10 mg in 200 ml vehicle per 3 days beginning on day 19,
n 5 3). Rats were perfused transcardially 6 hours after the last
injection and brain tissue prepared as described for experiment
1. Blood was collected from the aorta prior to infusion. Because
of the small number of animals, data from control and vehicle
groups were pooled; the same applied for hypothyroid and hy-
pothyroid plus vehicle groups.
Experiment 7. Rats (250–300 g, age 60–80 days, n 5 3 in
each group) were isolated and separated in three experimental
groups. Rats were eithermaintainedwith free access to food and
water or deprived of food for either 48 or 72h with water ad
libitum. On the morning of the experimental day, animals were
perfusedwith formalin as previously described (29). Brains were
removed, postfixed, immersed in 20% sucrose.
Figure 1. Effect of fasting on pro-TRH, D2 and PPII mRNA expression in mediobasal hypothalamus; experiment 1. mRNAs were detected by in situ
hybridization with [35S]-labeled cRNA probes; sections viewed at 5X under dark-field illumination. Upper row: photomicrographs of coronal slices
through the medial PVN hybridized with a pro-TRH mRNA probe; left: control; middle: rats submitted to 48 hours of fasting; right: rats submitted
to 72 hours of fasting. Second row: Photomicrographs of coronal slices through the mediobasal hypothalamus hybridized with a PPII mRNA probe.
Third row: Photomicrographs of coronal slices through the mediobasal hypothalamus hybridized with a D2 mRNA probe. Lower panels: the graphs
show the densitometric analyses of the in situ hybridization autoradiograms. Data were analyzed by one way ANOVA and post hoc Student-
Newman-Keuls multiple comparisons test. Data are mean 6 S.E.M. Pro-TRH: n 5 3–5; D2: n 5 3–5; PPII: n 5 4–5. *: P , .05, **: P , .01. III 5
third ventricle, scale bar 5 100 mm.
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In situ hybridization (ISH) and image analysis
Serial 18-mm coronal sections through the rostrocaudal ex-
tent of the ME were cut on a cryostat (OTF model, BRIGHT
Instruments Company Ltd, Huntingdon, UK), adhered to Su-
perfrost/Plus slides (Fisher Scientific, Pittsburgh, PA), desiccated
overnight at 42°C, and stored at –80°C until prepared for in situ
hybridization. Every fourth section of the ME (bregma –2.56 to
–3.14 mm) was hybridized with either a 644-bp single stranded
[35S]-UTP labeled RNA probe complementary to the coding re-
gion of the rat PPII gene (nucleotides 129–773) (17), or a 800-bp
single stranded [35S] UTP labeled cRNA probe complementary
to the entire coding region of the rat deiodinase 2 (D2) gene (30).
Sections at PVN level (mid and caudal, bregma –1.56 to –2.04)
were hybridized with a 1241-bp single stranded [35S] UTP la-
beled cRNA probe complementary to the rat pro-TRH (31).
Hybridization was performed as previously described (17).
Slides were dipped into emulsion, and the autoradiograms de-
veloped after 4 (pro-TRH), 11 (D2), 33 or 38 days (PPII) of
exposure at 4°C.
Silver grains were visualized under dark field illumination
with a 5X objective (Zeiss Axioscop microscope) and a CCD
Sony video camera. Positive areas were delineated, and inte-
grated density values (density x area) were measured in each
section usingMercator Explora Nova imaging software (La Ro-
chelle, France). For each ISH trial, the sum of the integrated
density values of up to six slices/animalwas calculated and taken
as one determination.
The anatomical distribution of hybridization data indicated
that results were specific for the targetmRNAs (Figures 1 and 4).
Pro-TRH mRNA signal was high in the PVN, in a distribution
pattern consistentwith published studies (32). In themediobasal
hypothalamus PPII mRNA was detected along the medial and
ventral parts of the border of the third ventricle wall, within the
ME and, with much lower concentration in the surrounding tis-
sue, consistent with previous results (16, 17). D2 mRNA coin-
cided with the distribution of tanycytes and was also detected in
the substance and external layer of the median eminence (33).
Immunocytochemistry and image analysis
Twenty-five mm coronal sections were used to perform pro-
TRH staining (29). Briefly, brain sections were incubated over-
night with an anti-pro-TRH antibody (1:3,000). Rabbit anti-
pro-TRH antibody was generated against C-terminal prepro-
TRH239–255 sequence (KQSPQVEPWDKEPLEE) plus a
tyrosine added at the N-terminal end (34). Sections were treated
with a biotinylated donkey antirabbit antibody and with Vec-
tastain Elite ABC kit. Visible signal was developed with a 3–39-
diaminobenzidine/nickel solution. Immunostaining of negative
control, which did not show any antiserum immunolabeling,
included sequential elimination of either the primary or second-
ary antibody from the staining procedure. Bright-field images
were acquired with an Eclipse 50i microscope and a DS-Ri1
digital camera.The softwareprogramAdobePhotoShop7.0was
used to combine the photomicrographs into plates and adjust
levels, contrast and brightness in the images. To determine the
total number of pro-TRH-immunoreactive (IR) cells in the me-
dial PVN, cells containing distinct black/purple precipitate were
quantified in one out of three complete series of coronal brain
sections. For analysis, the pro-TRH-IR cells of the PVN were
subdivided into parvo and magnocellular subregions (35) and
estimated in the parvocellular subregion of the mid level of the
PVN ranging between bregma –1.60 and –1.88 mm. Data were
corrected for double counting, according to the method of Ab-
ercrombie (36), and expressed as the number of pro-TRH-IR
cells per coronal section. Blind quantitative analysis was per-
formed independently by two observers.
Measurement of PPII, and thyroliberinase activities
PPII activity was determined as described (37). Membranes
were collected by centrifugation. Protein concentration was de-
termined by the Bradford assay. PPII and thyroliberinase activ-
ities were determined using TRH-bNA as substrate in a coupled
assay with excess dipeptidyl aminopeptidase IV (EC 3.4.14.5)
and inhibitors of pyroglutamyl peptidase I (EC 3.4.19.3), and of
prolylendopeptidase (EC3.4.21.26). En-
zymatic assays were performed at 37°C
under initial velocity conditions. In
agreement with previous data (17), in
control animals PPII specific activitywas
higher in the ME than in the anterior pi-
tuitary (experiment 3; control ME 5
48.8 6 2 pmoles bNA/min/mg protein;
control anterior pituitary 5 10.9 6 0.5;
control parietal cortex580.465.8.Dif-
ferences between groupswere significant
(n 5 19; P , .0001; ANOVA, followed
by Student-Newman-Keuls multiple
comparisons test). Since expression and
activity drastically diminish from the
third ventricle wall to the brain paren-
chyma (17), the activity of ME PPII was
not standardized per mg protein, but re-
ported by structure, to minimize varia-
tion due to dissection.
Liver deiodinase 1 activity
D1 activity was determined in liver
microsomes (10mg of protein) with 125I-
Figure 2. Effect of fasting on activity of PPII in ME, parietal cortex, anterior pituitary and serum;
experiment 3. The graphs show activity or specific activity of PPII in control animals and fasted
animals between 36–72 hours. Fasting increased PPII activity in the ME (A). Fasting did not
change specific activity of anterior pituitary or parietal cortex PPII (B, D). Fasting enhanced
thyroliberinase activity (C). White bars (control); black bars (fasted). Values are pmoles product
per min per tissue (A), or per mg protein (B, D), or per mL of serum (C). Data were analyzed by
one way ANOVA and post hoc Student-Newman-Keuls multiple comparisons test. Data are
mean 6 S.E.M. Panels A and B: n 5 5; Panel C: n 5 4–5; Panel D: n 5 4–5. *: P , .05.
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rT3 (Perkin Elmer, NEX109) as a substrate (38); the labeled
hormone was purified before use by chromatography on Sepha-
dex LH 20. Released 125I was separated by chromatography on
Dowex 50WX2, 100–200 mesh, and quantified with a gamma
counter. Blank values (without homogenate) were subtracted;
proteins were determined with the Bradford assay. Values were
linear with time (between 5 and 15 minutes) and protein con-
centration (between 5 and 10 mg protein). Specific activity val-
ues, and the effect of fasting on activity, were consistent with
previous studies (11, 12, 13), suggesting that the assay primarily
detected D1.
Measurements of hormone concentrations in
serum
Serum TSH levels were analyzed by RIA using rNIDDK re-
agents (Bethesda, MD). Serum corticosterone levels were ana-
lyzed by RIAwith reagents fromMerck-Millipore, Perkin Elmer
and Sigma. In experiments 2, 3 and 5, total serum T3 and T4
concentrations were analyzed by ELISA (Diagnóstica Interna-
cional, Méx). In experiment 4, total T3 and T4 concentrations
were analyzed by RIA with RK-6CT1 and RK-11CT1 kits (Sie-
mens Diagnostic Products Corporation; Los Angeles, CA) re-
spectively. Serum leptin concentrations were measured with an
ELISA kit (Crystal Chem Inc., Downers Grove, IL).
Detection limits: TSH: 25 ng/ml; T4-RIA: 30 nMol/L; T4-
ELISA: 16 nMol/L; T3-RIA or -ELISA: 0.3 nMol/L; corticoste-
rone: 25 ng/mL; leptin: 0.2 ng/mL. The intra-assay precision
was # 5%, # 10%, and # 4.3%, and the interassay precision
was # 9%, # 10%, and # 4.5% for TSH, corticosterone, and
leptin respectively. The intra assay precision was , 6.8% for
T4-RIA and, 4.3% for T4-ELISA,, 6.0% for T3-RIA and,
9.6% for T3-ELISA. The inter assay precision was , 6.0% for
T4-RIA and, 4.5% for T4-ELISA,, 10.6% for T3-RIA and,
10.3% for T3-ELISA. Proteins were determined with the Brad-
ford assay.
Statistical analysis
Results are presented as means 6 S.E.M. Statistical signifi-
cance between control and experimental groupswas determined
by unpaired t-Test (experiment 2) or one- or two-way ANOVA,
followed by Student-Newman-Keuls multiple comparisons test.
When data did not pass the normality test, they were reanalyzed
after transformation to root square or logarithm base 10. Dif-
ferenceswere considered significant atP, .05.ANOVAdataare
shown in Supplemental Table 1. Results of post hoc tests are
shown in figures, tables or text. For experiment 1, linear corre-
lation analyses were performed with Sigma Plot software and
considered significant when P # .05 (Supplemental Figure 3).
Results
Fasting increases PPII mRNA expression in the
mediobasal hypothalamus, PPII activity in the ME
and thyroliberinase activity in serum
To determine whether PPII expression in tanycytes is
regulated by fasting, we subjectedmale rats to either 48 or
72 hours of fasting (experiment 1). Serum TSH levels
tended to be lower in fasted than in control animals (con-
trol: 2.2 6 0.9, fasting 48 hours: 1.24 6 0.14, fasting 72
hours: 0.96 0.2 ng/mL, n5 5). PPII mRNA levels in the
ME were increased 2.5 fold at 48 hours of fasting. This
increase was transitory since PPII mRNA levels were sim-
ilar to control values at 72 hours of fasting (Figure 1). The
increase in PPII mRNA levels was even more intense, but
equally reversed with time, if PPII mRNA expression was
quantified in the ME together with the lateral ventricular
walls (ie, the region where both b and a tanycytes are
found) (not shown). These data suggest that PPII expres-
sion was regulated by fasting both in a and b tanycytes.
Since animals were isolated concomitantly with fasting
initiation, the results may have been dependent on the
stress produced by isolation (39). Thus, male rats accus-
tomed to isolation for 5 days were subjected to 48 hours
of fasting in an independent experiment (experiment 2).
Body weight gain dropped in fasted animals, and serum
TSH, T4 and T3 concentrations were lower in fasted than
in control animals (Supplemental Table 2). PPII mRNA
levels in the ME were increased 1.4 fold by 48 hours fast-
ing (Supplemental Figure 1); this result suggests that fast-
ing regulates ME PPII mRNA levels independently of iso-
lation. Therefore, the following experiments were done
according to experiment 1 protocol.
Two other experiments were performed to determine
the dynamics of fasting effects on PPII activity. In exper-
iment 3, fasting decreased body weight gain as well as
serumTSH, totalT3andT4concentrations, and increased
serum corticosterone levels; these effects were detected at
36 hours and/or at later time points (Table 1). In fed an-
imals, the ME PPII activity tended to decrease when the
time of isolation increased. Fasting enhancedME PPII ac-
Table 1. Body weight gain and serum hormone concentrations in normally fed male animals and 36–72 h of
fasting; experiment 3.
Control
36 h Fasting 36 h
Control
48 h Fasting 48 h
Control
60 h Fasting 60 h
Control
72 h Fasting 72 h
Body weight gaina 13.2 6 0.3 (5) 226.4 6 0.9 (5) *** 6.6 6 2.1 (5) 232.2 6 1.5 (5) *** 7 6 0.5 (5) 225.2 6 1.7 (5) *** 8.8 6 1.4 (5) 220.6 6 1 (5) ***
TSHb 1.60 6 0.1 (5) 1.16 6 0.1 (4) 2.15 6 0.2 (5) 1.49 6 0.1 (5) 2.87 6 0.5 (5) 1.32 6 0.1 (5) * 3.31 6 0.9 (5) 1.07 6 0.7 (5) ***
T3 (total)c 1.39 6 0.16 (5) 0.90 6 0.05 (4) * 1.45 6 0.13 (5) 1.25 6 0.11 (5) 1.40 6 0.10 (5) 1.14 6 0.15 (5) 1.34 6 0.11 (5) 0.79 6 0.09 (3) *
T4 (total)c 108 6 9 (5) 62.6 6 4.5 (5) *** 106 6 7.1 (5) 37 6 4.7 (5) *** 89.2 6 11.5 (5) 44.4 6 2.5 (5) *** 77.9 6 5.1 (5) 48.2 6 11.6 (5)
Cortico-steroneb 101 6 14.4 (5) 570 6 124 (4) * 121 6 20.9 (5) 253 6 65 (5) 26.8 6 4.2 (5) 587 6 116 (5) *** 34.2 6 12.1 (5) 215 6 75 (5) *
Serum proteinsd 74.3 6 6.5 (5) 68.8 6 5.1 (5) 77.4 6 2.3 (5) 66.1 6 3.9 (5) 71.7 6 3.4 (5) 74.4 6 2.5 (5) 72.7 6 3.0 (5) 69.7 6 8.3 (5)
Data are mean 6 SEM a: g; b: ng/mL; c: nMol/liter; d: mg/ml. Post hoc Student-Newman-Keuls multiple comparisons test: *: P , 0.05, ***: P ,
0.005, compared to control.
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tivity, with a significant increase at 72 hours of fasting
(Figure 2A). Notably, parietal cortex or anterior pituitary
PPII specific activities were not affected by fasting (Figure
2B, D). Finally, serum thyroliberinase activity in fasted
animals was increased after 48 hours of fasting, and at
later time points (Figure 2C).
In experiment 4, fasting decreased body weight gain,
serum concentrations of leptin, TSH, and total T4, as well
as liver D1 activity, while it increased serum corticoste-
rone concentration; these effectswere detected at 36hours
of fasting and/or at later time points (Supplemental Table
3). In fed animals, theME PPII activity tended to decrease
while the timeof isolation increased. Fasting increasedME
PPII activity between 48 and 72h, with significant effects
at 48 and 72 hours (Supplemental Figure 2A). Fasting
decreased parietal cortex PPII specific activity after 72
hours of fasting (Supplemental Figure 2D). In the anterior
pituitary, PPII specific activity was not affected by fasting
(Supplemental Figure 2B). Finally, serum thyroliberinase
specific activity was increased at 36 or more hours of fast-
ing (Supplemental Figure 2C).
Effect of adrenalectomy and corticosterone
treatment on PPII activity in the ME and
thyroliberinase activity in serum
Based on the relevance of adrenal status for HPT axis
activity (40) and the differential changes in serum corti-
costerone concentration during isolation and fasting, we
evaluated the effect of adrenalectomy and corticosterone
treatment on PPII activity in ME and serum (experiment
5). In adrenalectomized animals, corticosterone levels
were undetectable; implantationof pelletswith 25or 40%
corticosterone led to serum corticosterone values 3 or 4
fold higher than in sham animals (Figure 3A). Adrenalec-
tomy decreased body weight gain and serum protein con-
centration and failed to affect the relative concentration of
serum TSH (amount/mg protein). Corticosterone treat-
ment did not reverse the decrease in bodyweight gain, but
did reverse the serum protein concentration change, and
tended to decrease the relative concentration of serum
TSH (moles/mg protein). The relative serum concentra-
tions of total T3 and T4 were not affected by adrenalec-
tomy and corticosterone treatments. The relative concen-
tration of serum leptin tended to decrease with
adrenalectomy; this effect was partially reverted with cor-
ticosterone treatment (Table 2). Adrenalectomy and cor-
ticosterone treatments did not changeMEPPII activity, or
the specific activity of thyroliberinase (Figure 3B,C).
Thyroid status regulates PPII mRNA expression in
the mediobasal hypothalamus
In situ hybridization histochemistry data indicated that
ME D2 mRNA expression is enhanced after 48 hours of
fasting; however, it returned to fed values at 72 hours of
fasting (Figure 1). The ME PPII mRNA levels correlated
positivelywithMED2mRNAlevels (SupplementalFigure
3B). In experiment 6, we evaluated the sensitivity of PPII
mRNA expression in the rat ME to thyroid status. Me-
thimazole-induced hypothyroidism
increased serum TSH level at day 21
after treatment; treatment with T4
for 3 consecutive days beginning at
day 19 after methimazole treatment
reverted this serum TSH increase
(control: 2.14 6 0.5 ng/mL (2), me-
thimazole: 18.46 5.2 (4)*, methim-
azole1 T4: 3.86 0.3 (3), *: P, .05
compared to control). ISH data
show that hypothyroidismproduced
a drastic decrease inMEPPIImRNA
levels; this drop was reversed if me-
thimazole-treated animals were
treated with T4 for 3 consecutive
days and sacrificed 6 hours after the
last injection (Figure 4A-D).
Prolonged fasting partially
reinitiates pro-TRH expression
in the PVN
Data from experiment 1 showed
that 48 hours of fasting reduced pro-
Figure 3. Effect of adrenalectomy and corticosterone replacement on ME PPII activity and
thyroliberinase activity; experiment 5. The graphs show serum corticosterone concentrations, and
activity or specific activity of PPII in sham, adrenalectomized, and adrenalectomized animals
implanted with 25 or 40% corticosterone pellets at 72 hours. Adrenalectomy decreased serum
corticosterone concentration (A). Adrenalectomy and corticosterone implants did not change ME
PPII specific activity (B) or specific activity of thyroliberinase (C). Values are in ng/mL (A), pmoles
product per min per tissue (B), or per mg protein (C). Data were analyzed by one way ANOVA
and post hoc Student-Newman-Keuls multiple comparisons test. Data are mean 6 S.E.M. n 5 6,
except for adrenalectomy and adrenalectomy plus 25% corticosterone groups, n 5 5. *: P , .05,
**: P , .01, ***: P , .001.
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TRH mRNA levels in the medial and caudal parts of the
PVN; noticeably, pro-TRH mRNA levels at 72 hours of
fasting were intermediary between those in fed and 48
hours fasted animals (Figure 1). Pro-TRH mRNA values
correlated negatively with ME D2 mRNA levels (Supple-
mental Figure 3A). To confirm that PVN pro-TRH ex-
pression spontaneously reverts if fasting occurs for more
than 2 days, we quantified the number of pro-TRH cells
Figure 4. Effect of hypothyroidism and T4 restitution on expression of PPII in ME; experiment 6. PPII mRNA was detected by in situ hybridization
with a [35S]-labeled cRNA probe. A-C) dark-field photomicrographs of coronal sections through the medio basal hypothalamus (exposure time: 38
days); images are made by a collage of 16 images taken at 5X. A) rat injected with vehicle per 3 days beginning on day 19; B) rat made
hypothyroid with 0.1% methimazole 1 1% sodium perchlorate in drinking water per 21 days; C) hypothyroid rat treated with L-T4 (10 mg in 200
ml vehicle per 3 days beginning on day 19). D) The graph shows the densitometric analyses of in situ hybridization microradiograms (exposure
time: 33 days); data in vehicle group include intact (n 5 3) and vehicle (n 5 2) (200 ml sterile saline/ 0.01 N NaOH per 3 days beginning on day 19)
treated animals; data in hypothyroid group include data from hypothyroid (0.1% methimazole 1 1% sodium perchlorate in their drinking water
per 21 days, n 5 2), and hypothyroid 1 vehicle (200 ml per 3 days beginning on day 19; n 5 3) rats; hypothyroid 1 L-T4 (10 mg in 200 ml vehicle
per 3 days beginning on day 19, n 5 3. Data were analyzed by one way ANOVA and post hoc Student-Newman-Keuls multiple comparisons test.
Data are mean 6 S.E.M. *: P , .05. III5 third ventricle, scale bar 5 100 mm.
Table 2. Serum concentrations of TSH, thyroid hormones, and leptin in normally fed male animals
adrenalectomized (Adx) and treated with corticosterone (Cort); experiment 5.
Sham Adx
Adx 1 25%
Cort
Adx 1 40%
Cort
Body weight
gaina
24.33 6 3.09 (6) 217.8 6 4.23 (5)
*
221.4 6 3.85 (5)
*
216.0 6 3.52 (6)
*
Serum proteinb 47.9 6 2.67 (6) 34.0 6 3.92 (5) ** 44.7 6 3.3 (5) & 49.7 6 2.1 (6) &
TSHc 35.2 6 6.9 (6) 40.4 6 9.1 (5) 22.6 6 2.1 (5) 23.3 6 2.9 (6)
Leptinc 141 6 37.9 (6) 62.4 6 21.7 (5) 119 6 24.9 (5) 115 6 28.1 (6)
T3 (total)d 12.3 6 1.8 (6) 15.0 6 1.46 (5) 11.8 6 4.51 (5) 9.66 6 0.95 (6)
T4 (total)d 1620 6 400 (6) 2000 6 400 (5) 1390 6 164 (5) 1270 6 52.1 (6)
Data are mean 6 SEM a: g; b: mg/ml; c: ng/mg protein; d: nMol/mg protein. Post hoc Student-Newman-Keuls multiple comparisons test: *: P , 0.05,
**: P , 0.01 compared to sham; &: P , 0.05 compared to adrenalectomy.
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positive in the parvocellular subregion of the medial level
of the PVN in experiment 7. The number of pro-TRH
positive cells in themedial parvocellular regionof thePVN
decreased at 48 hours of fasting and increased towards
values found in fed animals at 72 hours of fasting (Figure
5).
Discussion
Multiple molecular changes in specific organs orchestrate
an inhibition ofHPT axis in response to fasting (1, 8). The
data obtained in this study indicate that regulation ofHPT
axis activity in response to fasting includes an adjustment
in ME PPII activity, the ectopeptidase that hydrolyzes
TRH, in male rats. This change in activity is probably
localized in tanycytes, including b2 tanycytes, since PPII
mRNA expression increased in cells that correspond to
tanycytes localization. PPII is likely present on the surface
of b2 tanycytes and expected to affect HPT axis activity
since in vitroPPII inhibition enhances the recoveryofTRH
released from the ME, and in vivo PPII inhibition aug-
ments serum TSH concentration in cold-stressed animals
(17). Thus, we propose that a delayed increase ofME PPII
activity during fasting contributes to reduce TRH concen-
tration in the portal blood (2), and therefore to down-
regulate HPT axis activity. The enhancement of the ex-
tracellularhydrolysis ofTRHmay limit thepossibility that
a partial reactivation of TRH neurons reinitiates thyroid
axis function when fasting is prolonged.
Prolonged fasting promotes a partial reactivation
of pro-TRH expression in the parvocellular PVN
and a reversion of D2 mRNA induction in the
mediobasal hypothalamus
Responses to fasting are likely dependent on its severity
(41), but the effect of fasting on the dynamics of D2 ex-
pression is poorly described. In male rats, D2 mRNA ex-
pression is enhanced after 72 hours of fasting in a and b
tanycytes (42). D2 activity increases in the MBH after 48
hours of fasting (43). In our experimental conditions, ME
D2 expression increased after 48 hours of fasting, but nor-
malized to values found in fed animals after 72 hours of
fasting. Known enhancers of D2 activity in MBH are the
inverse changes in circulating levels of corticosterone and
leptin (43), which may have led to the peak of expression
we detected after 48h of fasting. The drop in D2 expres-
sion in tanycytes after 72 hours of fasting may be due to a
reduction of serum corticosterone concentration, as ani-
mals habituated to the stress.
As for D2 expression, the effect of fasting on the dy-
namics of PVN pro-TRH mRNA expression and TRH
release in male rats is poorly defined; PVN pro-TRH
mRNA levels are lower after 48 to 65 hours of fasting as
compared to values detected in fed animals (2, 3, 4, 44).
We noticed a late and partial reversal of the fasting-in-
duced reduction in PVN pro-TRH mRNA expression.
This partial inversion was confirmed in an independent
experiment in which we measured the number of cells
immuno-reactive for pro-TRH in the parvocellular part of
the medial PVN. Immunohistochemical data were consis-
tent with ISH results, showing a reactivation of pro-TRH
translation during late fasting. ISH and immunohisto-
chemical data were consistent in two different strains
(Wistar in exp. 1 and Sprague-Dawley in exp. 7), in spite
of strain differences in serum thyroid hormones and cor-
ticosterone concentrations (45).
During fasting, the decrease of serum leptin concentra-
tion reduces PVN pro-TRH mRNA levels and TRH re-
lease (3, 6). An increase of T3production in tanycytesmay
be a necessary link for down regulation of PVN pro-TRH
mRNA levels (4), but data in D2 or thyroid hormone re-
ceptor b2 KO mice do not support this hypothesis (10,
46–48). As for D2 expression, a reduction in serum cor-
ticosterone concentration may drive the reactivation of
pro-TRH synthesis since, on a time scale of days gluco-
corticoids inhibit TRH mRNA levels in the PVN (40).
Figure 5. Effect of fasting on the number of TRH immunopositive
neurons in the medial PVN in male rats; experiment 7. Coronal slices of
the medial PVN immunolabeled with an antibody against pro-TRH. A:
control; B: rats submitted to 48 hours of fasting; C: rats submitted to
72 hours of fasting; D: quantification of pro-TRH immunoreactivity in
the medial PVN. Data are mean 6 S.E.M., n 5 3 *: P , .05. III5 third
ventricle, scale bar 5 100 mm.
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The partial reactivation of pro-TRH expression in
the PVN during late fasting coincides with an up-
regulation of PPII activity in the ME
An increase in PPII mRNA levels in the ME as well as
in the medial and ventral parts of the ventricle walls, pre-
sumably in tanycytes, was detected at 48 hours of fasting,
the earliest time point analyzed by ISH. This increase in
PPII expression was apparently independent of tanycyte
subtypes and reproduced in an independent experiment
with younger animals previously habituated to isolation.
Thus, enhanced expression of MBH PPII at 48 hours of
fasting is a consistent response, independent of adult an-
imal age (in the 2–4.5 month range) or housing condi-
tions. The increase in tanycyte PPII expression was tran-
sient, since it was not detected after 72 hours of fasting.
ME PPII activity was not affected by 36 hours of fasting
but increased either after 48 hours of fasting in one ex-
periment, or after 72 hours of fasting in another experi-
ment. Thus, an increase inMEPPII expression in response
to fasting produces a concomitant or delayed increase in
ME PPII activity.
TRH hydrolysis by PPII produces His-Pro-NH2, that
may be either hydrolyzed by dipeptidyl peptidase IV (49),
an enzymeabundanton the surfaceofmanycell types (50),
or spontaneously cyclize to cycloHis-Pro (49). CycloHis-
Pro is detected in the brain, including the hypothalamus;
it may not be uniquely derived from TRH (51, 52). How-
ever, it is relevant to note that cycloHis-Pro concentration
increases in thehypothalamusof fasted animals; themech-
anism leading to its accumulation has not been clarified
(51); it may be related to increased PPII activity in theME.
Together, these results suggest that during prolonged
fasting the catabolism of TRH by PPII is increased in the
ME extracellular fluid, concomitant with positive adjust-
ments in TRH expression in PVN neurons which, if un-
balanced, might partially reactivate TRH secretion in the
portal capillaries. The control of ME PPII activity may
thus contribute to maintain the reduction in the portal
concentration of TRH that is detected in rats subjected to
fasting (2, 53).
Putative drivers of up-regulation of PPII activity in
the ME during fasting
Up-regulation of PPII activity inMEduring fasting sug-
gests the activity is coordinatedwith other aspects of HPT
axis function. The hypothesis that adrenal status, which is
relevant for HPT axis activity (40), regulates ME PPII ac-
tivity in fed animals was not supported by our data. Thus,
it seems unlikely that the effect of fasting on ME PPII
activity is mediated by changes in serum corticosterone
concentration per se. It is however possible that the early
inverse changes in serum corticosterone and leptin con-
centrations that increase D2 activity in the MBH during
fasting (43) led together to an increase in MBH PPII ex-
pression. An effect of thyroid hormones on ME PPII ex-
pression and activity during fasting is consistent with
available data. Fasting increases not only D2 expression
and activity in ME (42, 43, this study), but also hypotha-
lamic T3 levels (4). Thyroid hormones up-regulate PPII
expression in all subtypes of tanycytes in the context of
thyrotoxicosis (17), or in hypothyroid mice, with changes
faster than those operating on pro-TRH synthesis in the
PVN (19); finally, tanycyte PPII expression is exquisitely
sensitive to thyroid status (this study). Thyroid hormones
positively regulatedPPII expression in tanycytes andMBH
regions from bregma –2.56 to –3.14 mm (Figure 4), while
brain PPII activity sensitivity to thyroid status is poor (20,
25). Thus, the opposite effects of fasting on PPII activity in
the cortex andmedian eminence coincide with region spe-
cific effects of thyroid hormones on PPII activity.
Fasting promotes an increase in the activity of
thyroliberinase in serum
Thyroliberinase was the first TRHhydrolyzing activity
biochemically characterized. Thyroliberinase activity in-
creased during fasting, with significant changes detected
relatively early (after 36 or 48 hours fasting) and main-
tained at least up to 72 hours of fasting. Since thyroid
hormones up-regulate thyroliberinase activity (24, 25),
the fasting-induced increase of thyroliberinase was unex-
pected. Additionally, thyroliberinase activity was insensi-
tive to manipulation of serum corticosterone levels in fed
animals.Themechanisms leading to enhanced thyroliberi-
nase activity during fasting remainunknown.The increase
in thyroliberinase activity detected in peripheral blood
presumably coincides with an increase of the activity of
this enzyme in the hypothalamus-pituitary portal blood
vessels, andmay contribute to reduce the concentration of
TRH reaching the thyrotrophs during fasting.
Relevance of anterior pituitary PPII activity
Since anterior pituitary PPII activity is sensitive to thy-
roid status and rapidly up-regulated by thyroid hormones
in vivo, it was initially proposed that PPII contributes to
the negative feedback that thyroid hormones exert on the
HPT axis (20, 25). However, PPII is not expressed by
thyrotrophs and does not control thyrotropin secretion in
response to TRH in cell culture (21, 22) suggesting that
PPII unlikely controls TSH secretion in this locus. We ob-
served that fasting does not modify PPII activity in the
anterior pituitary. Likewise, 7 days of food restriction in
adult female rats does not change the expression of PPII in
the anterior pituitary (54). It shouldbehowever noted that
48 hours of fasting decreases anterior pituitary PPII ac-
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tivity in 28 days old but not in three-month-old male rats
(55); the reason for this age-dependent response is un-
known. Thus, in adult animals anterior pituitary PPII ac-
tivity is not regulated by fasting andmay not contribute to
the adjustments of the HPT axis activity.
In conclusion, the initial drop of PVN pro-TRH ex-
pression in adult male rats that is induced by fasting is
partially reversed between 48 and 72 hours postfasting
initiation, when ME PPII as well as thyroliberinase activ-
ities are up-regulated. The adjustments of ME PPII and
thyroliberinase activities may oppose the partial reactiva-
tion of TRH secretion and contribute to the reduced HPT
axis activity that characterizes prolonged fasting. These
data reveal unsuspected fluctuations in the dynamics of
HPT axis during fasting, and are consistent with the evi-
dence that tanycytes respond to changes in energy balance
(10).
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